Ensign Peak Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
|
|||||
|
2025
Q1 | $27.7M | Buy |
|
|||||
|
2024
Q4 | $29.7M | Sell |
|
|||||
|
2024
Q3 | $44.9M | Sell |
|
|||||
|
2024
Q2 | $135M | Sell |
|
|||||
|
2024
Q1 | $128M | Sell |
|
|||||
|
2023
Q4 | $122M | Buy |
|
|||||
|
2023
Q3 | $105M | Buy |
|
|||||
|
2023
Q2 | $89.6M | Buy |
|
|||||
|
2023
Q1 | $39.9M | Sell |
|
|||||
|
2022
Q4 | $36.7M | Buy |
|
|||||
|
2022
Q3 | $34.9M | Sell |
|
|||||
|
2022
Q2 | $35.5M | Buy |
|
|||||
|
2022
Q1 | $31.9M | Sell |
|
|||||
|
2021
Q4 | $35.5M | Sell |
|
|||||
|
2021
Q3 | $54.4M | Sell |
|
|||||
|
2021
Q2 | $54.8M | Sell |
|
|||||
|
2021
Q1 | $48.4M | Sell |
|
|||||
|
2020
Q4 | $66.4M | Sell |
|
|||||
|
2020
Q3 | $84.7M | Sell |
|
|||||
|
2020
Q2 | $97M | Buy |
|
|||||
|
2020
Q1 | $41.6M | Buy |
|
|||||
|
2019
Q4 | $16M | Buy |
|